Insmed, Inc. (INSM)
164.91
+3.91
(+2.43%)
USD |
NASDAQ |
Feb 20, 16:00
164.92
+0.01
(+0.01%)
After-Hours: 20:00
Insmed SG&A Expense (Quarterly) : 0.00 for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Biogen, Inc. | 682.50M |
| Mirum Pharmaceuticals, Inc. | 61.91M |
| Madrigal Pharmaceuticals, Inc. | 0.00 |
| CorMedix, Inc. | 36.64M |